everlinQ Endovascular Access Systems Enhancements (EASE-2) Study
Not Applicable
Completed
- Conditions
- Chronic Kidney Diseases
- Interventions
- Device: everlinQ endoAVF System
- First Posted Date
- 2018-10-17
- Last Posted Date
- 2023-04-12
- Lead Sponsor
- TVA Medical Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT03708562
- Locations
- 🇵🇾
Sanatorio Italiano, Asunción, Paraguay
everlinQ Endovascular Access System Enhancements (EASE) Study
Not Applicable
Completed
- Conditions
- Chronic Kidney Diseases
- Interventions
- Device: everlinQ endoAVF System
- First Posted Date
- 2018-10-17
- Last Posted Date
- 2023-07-12
- Lead Sponsor
- TVA Medical Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT03708770
everlinQ endoAVF Post Market Study
Not Applicable
Terminated
- Conditions
- Chronic Kidney Disease
- Interventions
- Device: everlinQ endoAVF System
- First Posted Date
- 2016-02-15
- Last Posted Date
- 2021-11-17
- Lead Sponsor
- TVA Medical Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT02682420
- Locations
- 🇨🇦
Providence Health Care Society, Vancouver, British Columbia, Canada
🇬🇧St. George's University, London, United Kingdom
🇬🇧Oxford University Hospitals - NHS Foundation Trust, Headington, Oxford, United Kingdom
A Prospective Clinical Evaluation of the Total Vascular Access (TVA) FLEX-1 Device Protocol Flex-1-002-IR Intervention Reduction (IR)
Not Applicable
Completed
- Conditions
- Chronic Kidney Disease (CKD)
- Interventions
- Device: Endovasccular AVF (EndoAVF)
- First Posted Date
- 2014-04-22
- Last Posted Date
- 2014-04-22
- Lead Sponsor
- TVA Medical Inc.
- Target Recruit Count
- 17
- Registration Number
- NCT02119832
- Locations
- 🇵🇾
Italian Hospital, Asuncion, Paraguay
A Prospective Clinical Evaluation of the Total Vascular Access (TVA) FLEX-1 Device Protocol FLEX-1-001
Not Applicable
Completed
- Conditions
- Chronic Kidney Disease (CKD)
- Interventions
- Device: Endovascular AVF (EndoAVF)
- First Posted Date
- 2014-04-22
- Last Posted Date
- 2014-04-22
- Lead Sponsor
- TVA Medical Inc.
- Target Recruit Count
- 16
- Registration Number
- NCT02119845
- Locations
- 🇵🇾
Italian Hospital, Asuncion, Paraguay
Novel Endovascular Access Trial (NEAT)
Not Applicable
Completed
- Conditions
- Chronic Kidney Disease
- Interventions
- Device: The FLEX System will be used to percutaneously create a fistula in CKD patients who require hemodialysis vascular access
- First Posted Date
- 2014-01-15
- Last Posted Date
- 2018-07-27
- Lead Sponsor
- TVA Medical Inc.
- Target Recruit Count
- 80
- Registration Number
- NCT02036671
- Locations
- 🇨🇦
St. Paul's Hospital, Vancouver, British Columbia, Canada
🇨🇦QE II Health Sciences Center, Halifax, Nova Scotia, Canada
🇨🇦CHUM, Notre-Dame Hospital, Montreal, Quebec, Canada
© Copyright 2025. All Rights Reserved by MedPath